Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dilsen Cevirgen"'
Autor:
Sinem Nihal Esatoglu, Fatma Nihan Akkoc-Mustafayev, Yesim Ozguler, Fatma Ozbakır, Okan K. Nohut, Dilsen Cevirgen, Vedat Hamuryudan, Ibrahim Hatemi, Aykut Ferhat Celik, Hasan Yazici, Gulen Hatemi
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
BackgroundImmunogenicity of tumor necrosis factor alpha inhibitors (TNFis) has been recognized as an important problem that may cause loss of efficacy and adverse events such as infusion reactions. TNFis are being increasingly used among patients wit
Externí odkaz:
https://doaj.org/article/1b84734452af406395e02aad982f0ced
Autor:
Vedat Hamuryudan, Fatma Nihan Akkoc-Mustafayev, Sinem Nihal Esatoglu, Yesim Ozguler, Ibrahim Hatemi, Aykut Ferhat Celik, Gulen Hatemi, Okan Kadir Nohut, Dilsen Cevirgen, Fatma Ozbakir, Hasan Yazici
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology, Vol 11 (2020)
BackgroundImmunogenicity of tumor necrosis factor alpha inhibitors (TNFis) has been recognized as an important problem that may cause loss of efficacy and adverse events such as infusion reactions. TNFis are being increasingly used among patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e85bd2d1b874b811ca748cbc17d6ffc7
http://europepmc.org/articles/PMC7782473
http://europepmc.org/articles/PMC7782473
Autor:
Vedat Hamuryudan, Dilsen Cevirgen, F.N. Akkoc, Aykut Ferhat Celik, Sinem Nihal Esatoglu, Ibrahim Hatemi, Halil Yazici, Yesim Ozguler, Okan Kadir Nohut, Fatma Ozbakir, Gulen Hatemi
Publikováno v:
FRIDAY, 15 JUNE 2018.
Background Immunogenicity of anti-TNFs has been recognised as an important problem that may cause loss of efficacy and adverse events such as infusion reactions. Anti-TNFs are being increasingly used among patients with Behcet’s syndrome (BS). Obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b92944efd99ef148be3c73f7fa63a6f
https://doi.org/10.1136/annrheumdis-2018-eular.4777
https://doi.org/10.1136/annrheumdis-2018-eular.4777
Publikováno v:
Eurasian Journal of Medicine and Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::434301f8e2910f3f6ad7510763e5f7a0
https://doi.org/10.14744/ejmo.2017.46220
https://doi.org/10.14744/ejmo.2017.46220
Autor:
Emire, Seyahi, Eda, Tahir Turanli, Mehmet Serhat, Mangan, Gokce, Celikyapi, Veysel, Oktay, Dilsen, Cevirgen, Duygu, Kuzuoglu, Susan, Ozoglu, Hasan, Yazici
Publikováno v:
Clinical and experimental rheumatology. 28(4 Suppl 60)
We investigated the prevalence of Behçet's syndrome (BS) among the ethnic Armenians in Istanbul using Familial Mediterranean Fever (FMF) as a comparator disease. We also studied HLA-B51 and MEFV mutations among a group of healthy Armenians and a non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e051cd3dd3b3bc011c5aa62c4fdec58a
https://pubmed.ncbi.nlm.nih.gov/20868574
https://pubmed.ncbi.nlm.nih.gov/20868574